{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:26:20Z","timestamp":1768631180655,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12311-020-01106-w","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T14:02:43Z","timestamp":1580133763000},"page":"265-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-Tremor Action of Subtype Selective Positive Allosteric Modulators of GABAA Receptors in a Rat Model of Essential Tremors"],"prefix":"10.1007","volume":"19","author":[{"given":"Dipak V.","family":"Amrutkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tino","family":"Dyhring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janus S.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Sandager-Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"1106_CR1","doi-asserted-by":"crossref","unstructured":"Deuschl G, et al. Treatment of patients with essential tremor. The Lancet. Neurology. 2011;10(2):148\u201361.\u00a0","DOI":"10.1016\/S1474-4422(10)70322-7"},{"issue":"Suppl 1","key":"1106_CR2","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1016\/S1353-8020(13)70023-3","volume":"20","author":"ED Louis","year":"2014","unstructured":"Louis ED. Re-thinking the biology of essential tremor: from models to morphology. Parkinsonism Relat Disord. 2014;20(Suppl 1):S88\u201393.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1106_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.10003","volume":"17","author":"KC Brennan","year":"2002","unstructured":"Brennan KC, Jurewicz EC, Ford B, Pullman SL, Louis ED. Is essential tremor predominantly a kinetic or a postural tremor? A clinical and electrophysiological study. Mov Disord. 2002;17(2):313\u20136.","journal-title":"Mov Disord"},{"issue":"4","key":"1106_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4103\/0972-2327.194463","volume":"19","author":"S Sharma","year":"2016","unstructured":"Sharma S, Pandey S. Approach to a tremor patient. Ann Indian Acad Neurol. 2016;19(4):433\u201343.","journal-title":"Ann Indian Acad Neurol"},{"key":"1106_CR5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5334\/tohm.318","volume":"6","author":"W Ondo","year":"2016","unstructured":"Ondo W. Essential tremor: what we can Learn from current pharmacotherapy. Tremor Other Hyperkinet Mov (N Y). 2016;6:356.","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"1","key":"1106_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00236557","volume":"18","author":"R Llinas","year":"1973","unstructured":"Llinas R, Volkind RA. The olivo-cerebellar system: functional properties as revealed by harmaline-induced tremor. Exp Brain Res. 1973;18(1):69\u201387.","journal-title":"Exp Brain Res"},{"issue":"6","key":"1106_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11910-014-0450-z","volume":"14","author":"ED Louis","year":"2014","unstructured":"Louis ED. Understanding essential tremor: progress on the biological front. Curr Neurol Neurosci Rep. 2014;14(6):450.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"1106_CR8","first-page":"138","volume":"5","author":"FR Shourmasti","year":"2014","unstructured":"Shourmasti FR, et al. Riluzole ameliorates Harmaline-induced tremor in rat. Basic Clin Neurosci. 2014;5(2):138\u201343.","journal-title":"Basic Clin Neurosci"},{"key":"1106_CR9","doi-asserted-by":"crossref","unstructured":"Handforth A. Harmaline tremor: underlying mechanisms in a potential animal model of essential tremor. Tremor and other hyperkinetic movements (New York, N.Y.) 2012;2:02-92-769-1","DOI":"10.5334\/tohm.108"},{"issue":"4","key":"1106_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/WCO.0000000000000115","volume":"27","author":"ED Louis","year":"2014","unstructured":"Louis ED. Essential tremor: from bedside to bench and back to bedside. Curr Opin Neurol. 2014;27(4):461\u20137.","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"1106_CR11","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2967\/jnumed.109.074120","volume":"51","author":"H Boecker","year":"2010","unstructured":"Boecker H, Weindl A, Brooks DJ, Ceballos-Baumann AO, Liedtke C, Miederer M, et al. GABAergic dysfunction in essential tremor: an 11C-flumazenil PET study. J Nucl Med. 2010;51(7):1030\u20135.","journal-title":"J Nucl Med"},{"issue":"3","key":"1106_CR12","doi-asserted-by":"publisher","first-page":"e93159","DOI":"10.1371\/journal.pone.0093159","volume":"9","author":"J Ibanez","year":"2014","unstructured":"Ibanez J, et al. Effects of alprazolam on cortical activity and tremors in patients with essential tremor. PLoS One. 2014;9(3):e93159.","journal-title":"PLoS One"},{"issue":"4457","key":"1106_CR13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1126\/science.7394531","volume":"209","author":"JN Nestoros","year":"1980","unstructured":"Nestoros JN. Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex. Science. 1980;209(4457):708\u201310.","journal-title":"Science"},{"issue":"2","key":"1106_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/1531-8249(199908)46:2<249::AID-ANA15>3.0.CO;2-C","volume":"46","author":"PA Pahapill","year":"1999","unstructured":"Pahapill PA, Levy R, Dostrovsky JO, Davis KD, Rezai AR, Tasker RR, et al. Tremor arrest with thalamic microinjections of muscimol in patients with essential tremor. Ann Neurol. 1999;46(2):249\u201352.","journal-title":"Ann Neurol"},{"issue":"9","key":"1106_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrd3502","volume":"10","author":"U Rudolph","year":"2011","unstructured":"Rudolph U, Knoflach F. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov. 2011;10(9):685\u201397.","journal-title":"Nat Rev Drug Discov"},{"key":"1106_CR16","unstructured":"Sieghart W. Structure, pharmacology, and function of GABAA receptor subtypes. Advances in pharmacology (San Diego, Calif.) 2006;54:231\u201363."},{"issue":"3","key":"1106_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/pr.108.00505","volume":"60","author":"RW Olsen","year":"2008","unstructured":"Olsen RW, Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(a) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev. 2008;60(3):243\u201360.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1106_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1124\/jpet.300.1.2","volume":"300","author":"H Mohler","year":"2002","unstructured":"Mohler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002;300(1):2\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"1106_CR19","doi-asserted-by":"crossref","unstructured":"Atack JR. Development of Subtype-Selective GABAA Receptor Compounds for the Treatment of Anxiety, Sleep Disorders and Epilepsy, in GABA and Sleep: Molecular, Functional and Clinical Aspects, J.M. Monti, S.R. Pandi-Perumal, and H. M\u00f6hler, Editors. 2010, Springer Basel: Basel. p. 25\u201372","DOI":"10.1007\/978-3-0346-0226-6_2"},{"issue":"2","key":"1106_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/0269881111415731","volume":"26","author":"SL de Haas","year":"2012","unstructured":"de Haas SL, et al. The effects of TPA023, a GABAAalpha2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol. J Psychopharmacol. 2012;26(2):282\u201391.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"1106_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0269881106072343","volume":"21","author":"SL de Haas","year":"2007","unstructured":"de Haas SL, de Visser SJ, van der Post J, de Smet M, Schoemaker RC, Rijnbeek B, et al. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(a) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers. J Psychopharmacol. 2007;21(4):374\u201383.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"1106_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bcp.2014.12.010","volume":"93","author":"AG de Lucas","year":"2015","unstructured":"de Lucas AG, Ahring PK, Larsen JS, Rivera-Arconada I, Lopez-Garcia JA, Mirza NR, et al. GABAA alpha5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085. Biochem Pharmacol. 2015;93(3):370\u20139.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1106_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/mds.20331","volume":"20","author":"FC Martin","year":"2005","unstructured":"Martin FC, Thu le A, Handforth A. Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications. Mov Disord. 2005;20(3):298\u2013305.","journal-title":"Mov Disord"},{"issue":"3","key":"1106_CR24","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1124\/jpet.108.138859","volume":"327","author":"NR Mirza","year":"2008","unstructured":"Mirza NR, Larsen JS, Mathiasen C, Jacobsen TA, Munro G, Erichsen HK, et al. NS11394 [3\u2032-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy. J Pharmacol Exp Ther. 2008;327(3):954\u201368.","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"1106_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/jnnp.48.9.911","volume":"48","author":"LJ Findley","year":"1985","unstructured":"Findley LJ, Cleeves L, Calzetti S. Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry. 1985;48(9):911\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1106_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4137\/JCNSD.S6561","volume":"5","author":"P Hedera","year":"2013","unstructured":"Hedera P, Cibulcik F, Davis TL. Pharmacotherapy of essential tremor. J Cent Nerv Syst Dis. 2013;5:43\u201355.","journal-title":"J Cent Nerv Syst Dis"},{"key":"1106_CR27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5334\/tohm.229","volume":"4","author":"A Gironell","year":"2014","unstructured":"Gironell A. The GABA Hypothesis in Essential Tremor: Lights and Shadows. Tremor Other Hyperkinet Mov (N Y). 2014;4:254.","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"Pt 12","key":"1106_CR28","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/brain\/awm266","volume":"130","author":"ED Louis","year":"2007","unstructured":"Louis ED, Faust PL, Vonsattel JP, Honig LS, Rajput A, Robinson CA, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain. 2007;130(Pt 12):3297\u2013307.","journal-title":"Brain"},{"issue":"19","key":"1106_CR29","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/0024-3205(78)90560-X","volume":"23","author":"MJ Williamson","year":"1978","unstructured":"Williamson MJ, Paul SM, Skolnick P. Demonstration of [3H] diazepam binding to benzodiazepine receptors in vivo. Life Sci. 1978;23(19):1935\u201340.","journal-title":"Life Sci"},{"issue":"1","key":"1106_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0014-2999(80)90020-5","volume":"67","author":"HA Robertson","year":"1980","unstructured":"Robertson HA. Harmaline-induced tremor: the benzodiazepine receptor as a site of action. Eur J Pharmacol. 1980;67(1):129\u201332.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1106_CR31","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1124\/jpet.108.144568","volume":"327","author":"G Munro","year":"2008","unstructured":"Munro G, et al. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3\u2032-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain. J Pharmacol Exp Ther. 2008;327(3):969\u201381.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"1106_CR32","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.5664\/jcsm.26525","volume":"2","author":"D Nutt","year":"2006","unstructured":"Nutt D. GABAA receptors: subtypes, regional distribution, and function. J Clin Sleep Med. 2006;2(2):S7\u201311.","journal-title":"J Clin Sleep Med"},{"issue":"48","key":"1106_CR33","doi-asserted-by":"publisher","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","volume":"287","author":"E Sigel","year":"2012","unstructured":"Sigel E, Steinmann ME. Structure, function, and modulation of GABA(a) receptors. J Biol Chem. 2012;287(48):40224\u201331.","journal-title":"J Biol Chem"},{"key":"1106_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neuroscience.2013.01.008","volume":"236","author":"H Hortnagl","year":"2013","unstructured":"Hortnagl H, et al. Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain. Neuroscience. 2013;236:345\u201372.","journal-title":"Neuroscience"},{"issue":"2","key":"1106_CR35","first-page":"111","volume":"58","author":"TA Smith","year":"2001","unstructured":"Smith TA. Type a gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment. Br J Biomed Sci. 2001;58(2):111\u201321.","journal-title":"Br J Biomed Sci"},{"issue":"15","key":"1106_CR36","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1523\/JNEUROSCI.4209-09.2010","volume":"30","author":"LJ Martin","year":"2010","unstructured":"Martin LJ, Zurek AA, MacDonald J, Roder JC, Jackson MF, Orser BA. Alpha5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory. J Neurosci. 2010;30(15):5269\u201382.","journal-title":"J Neurosci"},{"issue":"1","key":"1106_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0014-5793(91)80573-L","volume":"283","author":"D Benke","year":"1991","unstructured":"Benke D, et al. Identification and immunohistochemical mapping of GABAA receptor subtypes containing the delta-subunit in rat brain. FEBS Lett. 1991;283(1):145\u20139.","journal-title":"FEBS Lett"},{"issue":"3","key":"1106_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1172\/JCI200523625","volume":"115","author":"JE Kralic","year":"2005","unstructured":"Kralic JE, Criswell HE, Osterman JL, O'Buckley TK, Wilkie ME, Matthews DB, et al. Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J Clin Invest. 2005;115(3):774\u20139.","journal-title":"J Clin Invest"},{"key":"1106_CR39","doi-asserted-by":"crossref","unstructured":"Osterman JL, et al. GABAA receptor a1 subunit knockout mice: A novel model of essential tremor. Movement Disorders, ed. M.S. LeDoux. 2005: Elsevier. 369\u201375.","DOI":"10.1016\/B978-012088382-0\/50033-5"},{"issue":"1\u20132","key":"1106_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neulet.2006.02.066","volume":"401","author":"H Deng","year":"2006","unstructured":"Deng H, Xie WJ, le WD, Huang MS, Jankovic J. Genetic analysis of the GABRA1 gene in patients with essential tremor. Neurosci Lett. 2006;401(1\u20132):16\u20139.","journal-title":"Neurosci Lett"},{"issue":"7","key":"1106_CR41","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/FPC.0b013e328345bec0","volume":"21","author":"E Garcia-Martin","year":"2011","unstructured":"Garcia-Martin E, et al. Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor. Pharmacogenet Genomics. 2011;21(7):436\u20139.","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"1106_CR42","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1124\/jpet.102.036665","volume":"302","author":"JE Kralic","year":"2002","unstructured":"Kralic JE, Korpi ER, O'Buckley TK, Homanics GE, Morrow AL. Molecular and pharmacological characterization of GABA(a) receptor alpha1 subunit knockout mice. J Pharmacol Exp Ther. 2002;302(3):1037\u201345.","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"1106_CR43","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","volume":"22","author":"N Collinson","year":"2002","unstructured":"Collinson N, Kuenzi FM, Jarolimek W, Maubach KA, Cothliff R, Sur C, et al. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci. 2002;22(13):5572\u201380.","journal-title":"J Neurosci"},{"key":"1106_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jchemneu.2017.04.006","volume":"82","author":"HJ Waldvogel","year":"2017","unstructured":"Waldvogel HJ, Munkle M, van Roon-Mom W, Mohler H, Faull RLM. The immunohistochemical distribution of the GABA(a) receptor \u03b1(1), \u03b1(2), \u03b1(3), \u03b2(2\/3) and \u03b3(2) subunits in the human thalamus. J Chem Neuroanat. 2017;82:39\u201355.","journal-title":"J Chem Neuroanat"},{"issue":"2","key":"1106_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0301-0082(02)00013-8","volume":"67","author":"ER Korpi","year":"2002","unstructured":"Korpi ER, Gr\u00fcnder G, L\u00fcddens H. Drug interactions at GABA(a) receptors. Prog Neurobiol. 2002;67(2):113\u201359.","journal-title":"Prog Neurobiol"},{"issue":"5","key":"1106_CR46","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","volume":"66","author":"WG Ondo","year":"2006","unstructured":"Ondo WG, Jankovic J, Connor GS, Pahwa R, Elble R, Stacy MA, et al. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology. 2006;66(5):672\u20137.","journal-title":"Neurology"},{"issue":"3","key":"1106_CR47","first-page":"1113","volume":"261","author":"M Facklam","year":"1992","unstructured":"Facklam M, Schoch P, Bonetti EP, Jenck F, Martin JR, Moreau JL, et al. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies. J Pharmacol Exp Ther. 1992;261(3):1113\u201321.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"1106_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejphar.2009.05.031","volume":"616","author":"NE Paterson","year":"2009","unstructured":"Paterson NE, Malekiani SA, Foreman MM, Olivier B, Hanania T. Pharmacological characterization of harmaline-induced tremor activity in mice. Eur J Pharmacol. 2009;616(1\u20133):73\u201380.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1106_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/jnnp.49.1.64","volume":"49","author":"WP Gorman","year":"1986","unstructured":"Gorman WP, et al. A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J Neurol Neurosurg Psychiatry. 1986;49(1):64\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1106_CR50","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/jnnp.36.4.618","volume":"36","author":"MH Morgan","year":"1973","unstructured":"Morgan MH, Hewer RL, Cooper R. Effect of the beta adrenergic blocking agent propranolol on essential tremor. J Neurol Neurosurg Psychiatry. 1973;36(4):618\u201324.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"1106_CR51","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.conb.2008.01.007","volume":"17","author":"SN Baker","year":"2007","unstructured":"Baker SN. Oscillatory interactions between sensorimotor cortex and the periphery. Curr Opin Neurobiol. 2007;17(6):649\u201355.","journal-title":"Curr Opin Neurobiol"},{"issue":"4","key":"1106_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000119347","volume":"35","author":"VA Feshchenko","year":"1997","unstructured":"Feshchenko VA, Veselis RA, Reinsel RA. Comparison of the EEG effects of midazolam, thiopental, and propofol: the role of underlying oscillatory systems. Neuropsychobiology. 1997;35(4):211\u201320.","journal-title":"Neuropsychobiology"},{"issue":"1","key":"1106_CR53","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1152\/jn.00539.2013","volume":"113","author":"EP Christian","year":"2015","unstructured":"Christian EP, Snyder DH, Song W, Gurley DA, Smolka J, Maier DL, et al. EEG-beta\/gamma spectral power elevation in rat: a translatable biomarker elicited by GABA(Aalpha2\/3)-positive allosteric modulators at nonsedating anxiolytic doses. J Neurophysiol. 2015;113(1):116\u201331.","journal-title":"J Neurophysiol"},{"issue":"10","key":"1106_CR54","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1046\/j.1460-9568.2003.02651.x","volume":"17","author":"C Kopp","year":"2003","unstructured":"Kopp C, Rudolph U, Keist R, Tobler I. Diazepam-induced changes on sleep and the EEG spectrum in mice: role of the alpha3-GABA(a) receptor subtype. Eur J Neurosci. 2003;17(10):2226\u201330.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"1106_CR55","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF02244432","volume":"105","author":"P Glue","year":"1991","unstructured":"Glue P, White E, Wilson S, Ball DM, Nutt DJ. Pharmacology of saccadic eye movements in man. 2. Effects of the alpha 2-adrenoceptor ligands idazoxan and clonidine. Psychopharmacology. 1991;105(3):368\u201373.","journal-title":"Psychopharmacology"},{"issue":"1","key":"1106_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0014-2999(95)00633-8","volume":"295","author":"P Abadie","year":"1996","unstructured":"Abadie P, Rioux P, Scatton B, Zarifian E, Barr\u00e9 L, Patat A, et al. Central benzodiazepine receptor occupancy by zolpidem in the human brain as assessed by positron emission tomography. Eur J Pharmacol. 1996;295(1):35\u201344.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1106_CR57","first-page":"789","volume":"180","author":"A Lingford-Hughes","year":"2005","unstructured":"Lingford-Hughes A, Wilson SJ, Feeney A, Grasby PG, Nutt DJ. A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist. Psychopharmacology. 2005;180(4):789\u201391.","journal-title":"Psychopharmacology"},{"key":"1106_CR58","first-page":"608912","volume":"2011","author":"S Nickolls","year":"2011","unstructured":"Nickolls S, et al. A comparison of the alpha2\/3\/5 selective positive allosteric modulators L-838,417 and TPA023 in preclinical models of inflammatory and neuropathic pain. Adv Pharmacol Sci. 2011;2011:608912.","journal-title":"Adv Pharmacol Sci"},{"issue":"12","key":"1106_CR59","first-page":"5773","volume":"62","author":"RM Owen","year":"2019","unstructured":"Owen RM, et al. Design and identification of a novel, functionally subtype selective GABAA positive allosteric modulator (PF-06372865). J Med Chem. 2019;62(12):5773\u201396.","journal-title":"J Med Chem"},{"issue":"2","key":"1106_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/cns.13046","volume":"25","author":"V Duveau","year":"2019","unstructured":"Duveau V, Buhl DL, Evrard A, Ruggiero C, Mand\u00e9-Niedergang B, Roucard C, et al. Pronounced antiepileptic activity of the subtype-selective GABAA -positive allosteric modulator PF-06372865 in the GAERS absence epilepsy model. CNS Neurosci Ther. 2019;25(2):255\u201360.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"1106_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/0269881109354928","volume":"25","author":"JR Atack","year":"2011","unstructured":"Atack JR, et al. Preclinical and clinical pharmacology of TPA023B, a GABAA receptor &alpha;2\/&alpha;3 subtype-selective partial agonist. J Psychopharmacol. 2011;25(3):329\u201344.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"1106_CR62","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00213-016-4506-4","volume":"234","author":"A Jucaite","year":"2017","unstructured":"Jucaite A, Csel\u00e9nyi Z, Lappalainen J, McCarthy D, Lee CM, Nyberg S, et al. GABAA receptor occupancy by subtype selective GABAAalpha2,3 modulators: PET studies in humans. Psychopharmacology. 2017;234(4):707\u201316.","journal-title":"Psychopharmacology"},{"issue":"4","key":"1106_CR63","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/bph.14119","volume":"175","author":"SA Nickolls","year":"2018","unstructured":"Nickolls SA, Gurrell R, van Amerongen G, Kammonen J, Cao L, Brown AR, et al. Pharmacology in translation: the preclinical and early clinical profile of the novel alpha2\/3 functionally selective GABAA receptor positive allosteric modulator PF-06372865. Br J Pharmacol. 2018;175(4):708\u201325.","journal-title":"Br J Pharmacol"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-020-01106-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12311-020-01106-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-020-01106-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:50:55Z","timestamp":1611622255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12311-020-01106-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1106"],"URL":"https:\/\/doi.org\/10.1007\/s12311-020-01106-w","relation":{},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"27 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance With Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}